By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Arrowhead Research Corporation 

1118 East Green Street

Pasadena  California  91106  U.S.A.
Phone: 626-792-5549 Fax: 626-792-5554


SEARCH JOBS

Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus and obesity and partner-based programs in oncology.


Key Statistics


Email: info@arrowres.com
Ownership: Public

Web Site: Arrowhead Research Corporation
Employees:
Symbol: ARWR
 



Industry
Medical Device






Company News
Arrowhead Research Corporation (ARWR) Issues Open Letter To Shareholders 10/9/2014 9:07:51 AM
Arrowhead Research Corporation (ARWR) To Present ARC-520 Phase 2a Data In Late-Breaking Session At American Association for Study of Liver Diseases Liver Meeting® 2014 10/8/2014 11:04:31 AM
Arrowhead Research Corporation (ARWR) To Present At 10th Annual Meeting Of The Oligonucleotide Therapeutics Society 10/7/2014 8:32:58 AM
Arrowhead Research Corporation (ARWR) Expands Management Team With Appointment Of Susan Boynton As Vice President Global Regulatory Affairs 9/30/2014 9:49:04 AM
Arrowhead Research Corporation (ARWR) To Present At Biocentury’s NewsMakers In The Biotech Industry Conference 9/22/2014 9:19:34 AM
Arrowhead Research Corporation (ARWR) Reports Fiscal 2014 Third Quarter Financial Results And Provides Update On ARC-520 8/13/2014 7:54:49 AM
Arrowhead Research Corporation (ARWR) To Report Fiscal 2014 Third Quarter Financial Results 8/1/2014 9:05:20 AM
Arrowhead Research Corporation (ARWR) Announces New Clinical Candidate ARC-AAT For Treatment Of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 6/19/2014 10:21:38 AM
Arrowhead Research Corporation (ARWR) Issues A Statement On Intellectual Property Protection For ARC-520 6/16/2014 10:52:31 AM
Arrowhead Research Corporation (ARWR) Set To Join Russell 3000 Index 6/16/2014 8:45:56 AM
12345678910...
//-->